We have examined whether VBIT-4, a novel inhibitor of VDAC activity and oligomerization, is capable of preventing the development of hyperglycemia-induced changes in the mitochondrial membrane potential, ROS generation, and the susceptibility of the organelles to the opening of the MPT pore. This evidence concerns the gene VDAC1 and Hyperglycemia.